Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients

NCT04046094 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Ascorbic Acid

Sponsor

University of Kansas Medical Center

Collaborators

[object Object]